ValueAct Capital
As of Q2 2026, ValueAct Capital reported 18 long-equity positions worth $5.63B in aggregate.
Copy-investor backtest
- Latest quarter
- +11.81%
- 1-year
- -6.13%
- 3-year
- +68.78%
- 5-year
- +54.42%
- 3-year vs S&P 500
- -4.46%
- 5-year vs S&P 500
- -19.26%
- 5-year top 5
- +37.05%
Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.
Get email alerts when ValueAct Capital files a new 13F — sign in or create a free account.
Updated 2026-06-06 from SEC 13F data.
Live quotes available for 10 of 15 rows. Rows without a quote are marked unavailable.
| 1 | STX | SEAGATE TECHNOLOGY PLC | 20.61% | Reduce -23.7% | 23,011,223 | $1.77B | $76.75 | |
| 2 | C | CITIGROUP INC | 18.44% | Reduce -19.6% | 21,723,719 | $1.58B | $72.75 | |
| 3 | KKR | KKR & CO INC | 18.01% | Reduce -17.0% | 31,584,672 | $1.54B | $48.85 | |
| 4 | LKQ | LKQ CORP | 10.65% | - | 21,547,746 | $912.12M | $42.33 | |
| 5 | CBRE | CBRE GROUP INC | 9.45% | - | 10,229,820 | $809.28M | $79.11 | |
| 6 | TRN | TRINITY INDS INC | 7.68% | Reduce -14.4% | 23,105,855 | $658.29M | $28.49 | |
| 7 | BHC | BAUSCH HEALTH COS INC | 6.65% | - | 17,941,603 | $569.47M | $31.74 | |
| 8 | SLM | SLM CORP | 5.51% | Reduce -18.6% | 26,294,254 | $472.51M | $17.97 | |
| 9 | NSIT | INSIGHT ENTERPRISES INC | 1.23% | New | 1,100,000 | $104.96M | $95.42 | |
| 10 | FI | FISERV INC | 1.19% | Add +162.0% | 860,000 | $102.37M | No quote | No quote |
| 11 | BLD | TOPBUILD CORP | 0.54% | New | 221,770 | $46.45M | No quote | No quote |
| 12 | OUT | OUTFRONT MEDIA INC | 0.04% | New | 157,448 | $3.44M | $21.83 | |
| 13 | CBAHWS | CBRE ACQUISITION HLDGS INC | 0.00% | New | 18,417 | $17K | No quote | No quote |
| 15 | MS | MORGAN STANLEY | - | Sold | 0 | $0 | No quote | No quote |
| 14 | CDW | CDW CORP | - | Sold | 0 | $0 | No quote | No quote |